Patent details

EP2632467 Title: CDK INHIBITORS

Basic Information

Publication number:
EP2632467
PCT Application Number:
PCT/US/2011/057749
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP118385459
PCT Publication Number:
WO/2012/061156
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CDK INHIBITORS
French Title of Invention:
INHIBITEURS DE CDK
German Title of Invention:
CDK-HEMMER
SPC Number:

Dates

Filing date:
25/10/2011
Grant date:
22/06/2016
EP Publication Date:
22/06/2016
PCT Publication Date:
10/05/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
04/09/2013
EP B1 Publication Date:
22/06/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
25/10/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/10/2011
 
 

Name:
G1 Therapeutics Inc.
Address:
79 T.W. Alexander Drive 4401 Research Commons, Suite 105, Research Triangle Park, NC 27709, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
06/07/2016
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
STRUM Jay C.
Address:
United States (US)

2

Name:
TAVARES Francis, X.
Address:
United States (US)

Priority

Priority Number:
406498 P
Priority Date:
25/10/2010
Priority Country:
United States (US)

Classification

Main IPC Class:
C07D 487/14;

Annual Fees

Annual Fee Due Date:
31/10/2025
Annual Fee Number:
15
Annual Fee Amount:
213 Euro
Expected Payer:
Last Annual Fee Payment Date:
11/10/2024
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
198 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages